Edwards Lifesciences Corp (EW) Stock Analysis

Edwards Lifesciences Corp (EW) is a publicly traded company in the HEALTHCARE sector. It trades at $87.66, carries a market capitalization of $50.76B, a price-to-earnings ratio of 47.65. This page summarizes the public market data, fundamentals, and frequently asked questions for EW, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE

Key Metrics

• Price: $87.66
• Market Cap: $50.76B
• P/E Ratio: 47.65
• EPS: $1.85
• 52-Week High: $89.14
• 52-Week Low: $72.30

Market Sentiment

Edwards Lifesciences Corp currently has a Neutral sentiment score of 0.04.

About Edwards Lifesciences Corp

Edwards Lifesciences Corp is a prominent American medical technology firm headquartered in Irvine, California, specializing in heart valve therapies and hemodynamic monitoring. Renowned for its innovative transcatheter heart valve technologies, the company is dedicated to developing advanced solutions for patients with heart diseases, ultimately aiming to enhance clinical outcomes and improve patient quality of life. With a strong market presence and a pipeline rich in cutting-edge products, ...

GNG Research Analysis

GNG Research scores Edwards Lifesciences Corp (EW) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for EW.

Frequently Asked Questions

Does EW pay dividends?

Edwards Lifesciences Corp (EW) does not currently pay a regular dividend.

What is EW's P/E ratio?

Edwards Lifesciences Corp has a price-to-earnings (P/E) ratio of 47.65.

What is EW's market cap?

Edwards Lifesciences Corp (EW) has a market capitalization of $50.76B with a current stock price of $87.66.